Infection Control Today Magazine - healthcare-acquired infections (HAIs), hospital infections, infection prevention and control, healthcare epidemiology, aseptic technique, environmental hygiene, hand hygiene, disinfection and sterilization, outbreak investigation, surveillance

FEATURES

CDC Protocols Cut Dialysis Infections

The Centers for Disease Control and Prevention (CDC) has released results of its Dialysis Bloodstream Infection Prevention Collaborative showing a 32 ...read more

Antimicrobial Resistance

The resistance of bacteria to antibiotics and similar drugs—called antimicrobials—is considered a major public health threat by the Food and Drug ...read more

Clostridium difficile

This report explores the essentials of Clostridium difficile, one of the most problematic pathogens facing healthcare institutions today. It provides ...read more

Clostridium difficile

Infection Control Today reports on the prevalence of Clostridium difficile, including hospitals' efforts to prevent and control this ...read more

Latest Headlines

Preoperative Measures to Prevent Surgical Site Infections

We regret to report there has been an error in the April, 2001 issue of Infection Control Today®. In the Best Practices article entitled “Preoperative Measures to Prevent Surgical Site Infections,” by Carolyn A. Ramsey, we incorrectly labeled the answer for test question #8 ...More
April 1, 2001
Posted in Articles
Infection Control Today - 04/2001: What's Happening in Enzymatic Cleaning?

What's Happening in Enzymatic Cleaning? By Kelli M. Donley Before After Figure 1: Endoscope before and after being cleaned with Olestrazyme. Frank Bass and Bernard Esquenet never thought barnacles would lay the foundation for their careers. Ironically, it was marine ...More
April 1, 2001
Posted in Articles
Process Concepts

Understanding the FDA Approval Process By Desiree Crawford, BS; Kay Mary Harrell, BS, JD; Lawton Seal, PhD; and Vicki Worthington Increased regulation for approval of articles intended for use in diagnosis, cure mitigation treatment, or prevention of disease in man or other ...More
April 1, 2001
Posted in Articles
Patient Safety, FDA Requirements and an Effective Recall Process

Patient Safety, FDA Requirements and an Effective Recall Process By Edwin Ross, BS, MS For half of the last decade (1995-2000), awareness has been heightened concerning patient safety. Organizations such as Health Care Financing Administration (HCFA) and the Joint ...More
April 1, 2001
Posted in Articles, Disinfection & Sterilization
Enzymatic Cleaning Solution for a Clean Bill of Health: Is itsafe?

Enzymatic Cleaning Solution for a Clean Bill of Health: Is it safe? By Brian Kern Every healthcare facility struggles to define exactly when an instrument is safe for surgical use. Prior handling by Central Services (CS) is also scrutinized to ensure the safety of hospital ...More
April 1, 2001
Posted in Articles
HIV Becoming Women's Disease

CHICAGO-A new study published in the Journal of the American Medical Associationsays HIV is increasingly becoming a women's disease. Further research is necessary on HIV pathogenesis and therapy in women. The study reviewed surveillance and prospective cohort studies ...More
March 30, 2001
Posted in News
Sexually Risky Behavior Increasing

ATLANTA, Ga-The Centers for Disease Control and Prevention (CDC) reported that a recent syphilis outbreak in Southern California has alerted officials of increased risky behavior. The outbreak in men who have sex with men (MSM) indicates that rates of unsafe sex are on the ...More
March 29, 2001
Posted in News
Calypte Biomedical Awarded ISO Certification

ALAMEDA, Calif-Calypte Biomedical Corporation has received IS 9001, EN 46001, and ISO 13485 certification. ISO certification is recognized for the using best manufacturing practices in a wide variety of products, including medical devices. ISO is an international standards ...More
March 29, 2001
Posted in News
Genotypic Analysis of Drug-Resistant HIV Cost-Effective

WESTPORT, Conn-Genotypic analysis of drug-resistant HIV strains appears to be cost-effective. A new study conducted by Milton C. Weinstein, MD, from the Harvard School of Public Health, used an HIV simulation model to incorporate data from several HIV-related trials to ...More
March 22, 2001
Posted in News
Paratek Appoints New Vice President

BOSTON-Paratek Pharmaceuticals, Inc., has appointed S. Ken Tanaka, Ph.D, as vice president of research and development. Tanaka's primary responsibilities with Paratek will be to oversee the company's innovative tetracycline and MAR (Multiple Antibiotic Resistance) programs, ...More
March 22, 2001
Posted in News